2018-10-31
Hoping for a New Horizon : Phase I oncology clinical trials medical outcomes & patients’ perspectives
Publication
Publication
Hopen op een nieuwe horizon : Klinisch oncologisch fase I onderzoek Medische uitkomsten & patiëntperspectieven
The primary aim of phase I trials is to establish safety profiles. Patients with advanced cancer, without standard treatment options, may struggle to decide whether to engage in a treatment with unknown efficacy, benefit, and side effects, or to opt for symptom-oriented palliative care. In this thesis, both medical outcomes of phase I clinical trials, as well as research towards patients‘ perspectives are presented.
| Additional Metadata | |
|---|---|
| , , , , | |
| A.H.J. Mathijssen (Ron) , M.J.A. de Jonge (Maja) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/111754 | |
| Organisation | Department of Medical Oncology |
|
van der Biessen, D. (2018, October 31). Hoping for a New Horizon : Phase I oncology clinical trials medical outcomes & patients’ perspectives. Retrieved from http://hdl.handle.net/1765/111754 |
|
